8th March 2024

German pharmaceutical company Bayer announced that it will invest US$200mn in a new plant in El Coyol, Alajuela, Costa Rica. The site is currently installing equipment and acquiring certification to begin production of contraceptives by the beginning of 2025. The aim is to provide access to long-acting, reversible contraception to 100 million women in low-middle income countries by 2030. Further investment in its research and development station in Guanacaste will increase production and the workforce by 18%. Bayer has had a presence in Costa Rica since 1997.

The full publication is available internationally on a subscription-only basis. SUBSCRIBE TO A FREE TRIAL

Photo: Coyol Free Zone